Glucosamine may lower chances of lung cancer
Inflammation plays an important role in developing lung cancer. Previous studies have linked anti-inflammatories such as glucosamine, chondroitin and non-steroidal anti-inflammatory drugs (NSAIDs) to lowering the chances.

In one study, researchers asked 76,904 people to report the glucosamine, chondroitin and NSAIDs they had taken during the previous 10 years.

Doctors found no links to chondroitin or NSAIDs, but compared to those who did not take glucosamine, those who had taken glucosamine at least four days per week for at least three years were 51 percent less likely to develop lung cancer (adeno-carcinoma).

Previous Next Back to Top
More Related Articles